Search research articles
Contact Us
Filters
Showing results (411-420 of 558) with videos related to
Page
of 56
Sort By:
The Journal of Trauma
|
March 1, 1996
Subcutaneous tissue oxygen pressure: a reliable index of peripheral perfusion in humans after injury
W Drucker, F Pearce, L Glass-Heidenreich, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2018
A posttranslational modification of the mitotic kinesin Eg5 that enhances its mechanochemical coupling and alters its mitotic function
Joseph M Muretta, Babu J N Reddy, Guido Scarabelli, et al.
Journal of Neurovirology
|
January 6, 2021
Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeutic targets
Carla Mavian, Andrea S Ramirez-Mata, James Jarad Dollar, et al.
Acta Neuropathologica Communications
|
June 1, 2021
Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches
Sajina Shakya, Anthony D Gromovsky, James S Hale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2007
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J Vredenburgh, Annick Desjardins, James E Herndon, et al.
The Journal of Clinical Investigation
|
June 21, 2016
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation
Qi Xie, Qiulian Wu, Leo Kim, et al.
Neuro-Oncology
|
March 25, 2008
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma
David A Reardon, Annick Desjardins, James J Vredenburgh, et al.
The Journal of Clinical Investigation
|
January 2, 2026
Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels
Fanen Yuan, Xujia Wu, Huairui Yuan, et al.
Neuro-Oncology
|
March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Jennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Nature Neuroscience
|
September 3, 2013
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
William A Flavahan, Qiulian Wu, Masahiro Hitomi, et al.
Page
of 56
Search research articles
Search
Showing results (411-420 of 558) with videos related to
Sort By:
Page
of 56
The Journal of Trauma
|
March 1, 1996
Subcutaneous tissue oxygen pressure: a reliable index of peripheral perfusion in humans after injury
W Drucker, F Pearce, L Glass-Heidenreich, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2018
A posttranslational modification of the mitotic kinesin Eg5 that enhances its mechanochemical coupling and alters its mitotic function
Joseph M Muretta, Babu J N Reddy, Guido Scarabelli, et al.
Journal of Neurovirology
|
January 6, 2021
Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeutic targets
Carla Mavian, Andrea S Ramirez-Mata, James Jarad Dollar, et al.
Acta Neuropathologica Communications
|
June 1, 2021
Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches
Sajina Shakya, Anthony D Gromovsky, James S Hale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2007
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J Vredenburgh, Annick Desjardins, James E Herndon, et al.
The Journal of Clinical Investigation
|
June 21, 2016
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation
Qi Xie, Qiulian Wu, Leo Kim, et al.
Neuro-Oncology
|
March 25, 2008
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma
David A Reardon, Annick Desjardins, James J Vredenburgh, et al.
The Journal of Clinical Investigation
|
January 2, 2026
Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels
Fanen Yuan, Xujia Wu, Huairui Yuan, et al.
Neuro-Oncology
|
March 18, 2009
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Jennifer A Quinn, Sara Xiaoyin Jiang, David A Reardon, et al.
Nature Neuroscience
|
September 3, 2013
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
William A Flavahan, Qiulian Wu, Masahiro Hitomi, et al.
Page
of 56